课题基金 / 基金详情

Inflammation Genomics and Atherosclerosis

Inflammation Genomics and Atherosclerosis
炎症基因组学和动脉粥样硬化
批准号:
6534706
负责人:
DAVID Stuart SISCOVICK
金额:
$58.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-16 至 2007-07-31

项目摘要

项目成果

DAVID Stuart SISCOVICK的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):生物学的进展表明,动脉粥样硬化可能部分反映了慢性炎症的血管后果。利用华盛顿大学NHLBI基因组应用计划(PGA)产生的一组候选基因的完整序列变异和常见单倍型的信息,我们建议在年轻成人冠状动脉危险因素发展(CARDIA)研究中检查炎症/血栓形成基因的常见变异与中间定量表型和亚临床冠状动脉粥样硬化的相关性,双种族队列研究。这组25个候选基因涉及通路(细胞因子、趋化因子及其受体;细胞粘附分子;和凝血蛋白),并包括几个受体-配体对。利用分支分析和PGA的资源,我们将识别一组有限的单核苷酸多态性(每个基因范围3-10个SNP),这些多态性表征非洲裔和欧洲裔人群中这些候选基因的常见单倍型。将对来自CARDIA第10年检查(n = 3,950例受试者)的DNA进行基因分型,以确定表征常见单倍型的选定变体。关于常见变异和单倍型的数据将纳入CARDIA研究数据库。两个重要的中间表型,纤维蛋白原和C-反应蛋白(CRP)的水平先前确定。对CARDIA参与者在15年级时进行冠状动脉粥样硬化(定义为冠状动脉钙化(CAC)的存在)的非侵入性评估。分析将按种族/民族分层,并重点关注常见单倍型与成人早期测量的纤维蛋白原、CRP和CAC的相关性。其次,我们将探讨可能的基因-基因和基因-环境的相互作用。拟议的多学科合作应提高敏感性和特异性的努力,以评估炎症/血栓形成的候选基因和心血管风险在年轻人的集合中的常见变异的关联。
英文摘要
DESCRIPTION (provided by applicant): Advances in biology suggest that atherosclerosis may reflect, in part, the vascular consequences of chronic inflammation. Using information on complete sequence variation and common haplotypes on a set of candidate genes generated through the NHLBI Program in Genomic Applications (PGA) at the University of Washington, we propose to examine the associations of common variation in inflammation/thrombosis genes with intermediate quantitative phenotypes and subclinical coronary atherosclerosis in the Coronary Artery Risk Factor Development in Young Adult (CARDIA) Study, a large, bi-racial cohort study. The set of 25 candidate genes involve pathways (cytokines, chemokines, and their receptors; cellular adhesion molecules; and, coagulation proteins) and include several receptor-ligand pairs. Using cladistic analysis and the resources of the PGA, we will identify a limited set of single nucleotide polymorphisms (range 3-10 SNPs per gene) that characterize common haplotypes in these candidate genes within persons of African descent and European descent. DNA from the CARDIA Year 10 examination (n = 3,950 subjects) will be genotyped for the selected variants that characterize the common haplotypes. Data on the presence of common variants and haplotypes will be incorporated into the CARDIA Study database. Levels of two important intermediate phenotypes, fibrinogen and C-reactive protein (CRP) were previously determined. Non-invasive assessment of coronary atherosclerosis, defined as the presence of coronary artery calcification (CAC), was obtained on CARDIA participants at the Year 15 exam. Analyses will be stratified by race/ethnicity and focus on the associations of the common haplotypes with fibrinogen, CRP, and CAC measured in early adult life. Secondarily, we will explore possible gene-gene and gene-environment interactions. The proposed multi-disciplinary collaboration should enhance the sensitivity and specificity of efforts to assess the associations of common variation in sets of inflammation/thrombosis candidate genes and cardiovascular risk in young adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome-wide study of sudden cardiac arrest in the community
  • 批准号:
    7653036
  • 项目类别:
  • 资助金额:
    $192.83万
  • 财政年份:
    2009
  • 负责人:
    DAVID Stuart SISCOVICK
  • 依托单位:
Genome-wide study of sudden cardiac arrest in the community
  • 批准号:
    7932176
  • 项目类别:
  • 资助金额:
    $174.34万
  • 财政年份:
    2009
  • 负责人:
    DAVID Stuart SISCOVICK
  • 依托单位:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
  • 批准号:
    8011714
  • 项目类别:
  • 资助金额:
    $69.77万
  • 财政年份:
    2008
  • 负责人:
    DAVID Stuart SISCOVICK
  • 依托单位:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
  • 批准号:
    7585808
  • 项目类别:
  • 资助金额:
    $72.18万
  • 财政年份:
    2008
  • 负责人:
    DAVID Stuart SISCOVICK
  • 依托单位:
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究